Abstract
Background Methicillin-Resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide. When patients are transferred between wards within a hospital, their risk of acquiring MRSA may change. In this study, we investigated how ward characteristics and connectivity are associated with MRSA acquisition.
Methods We analysed electronic medical records on patient transfers and MRSA screening of in-patients at an acute-care tertiary hospital in Singapore to investigate whether ward characteristics and connectivity within the hospital network were associated with MRSA acquisition rates over a period of four years.
Results Most patient transfers concentrated in a stable core network of wards. Factors associated with increased rate of MRSA acquisition were ward MRSA admission prevalence (rate ratio (RR): 1.50, 95% CI: 1.28, 1.71, per one percentage point increase), admission to a critical care ward (RR: 1.86, 95% CI: 1.14, 3.06) and average number of patients in the ward on a typical day (RR: 1.31, 95% CI: 1.02, 1.68, for every 10 patients quarterly). Admission to an oncology ward (RR: 0.61, 95% CI: 0.40, 0.93) (compared to medical ward), and median length of stay (RR: 0.71, 95% CI: 0.54, 0.93) were associated with lower acquisition rates. We did not find evidence that network measures of ward connectivity, including in-degree, weighted in-degree, influenced MRSA acquisition rate after adjusting for other ward characteristics.
Conclusion Ward MRSA admission prevalence, critical care ward, ward patient capacity, ward specialty, and median length of stay, rather than relative connectivity of the ward in the hospital network were associated with MRSA acquisition.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical exemption for this secondary data analysis was obtained from the National Healthcare Group Domain Specific Review Board (reference number: 2018/00890).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We do not have the permission to share the data.